Search

everythinglearnresearchcommunity

for

Search:↓

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Iron deficiency might contribute to hair loss in women.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

A woman got a rare condition called oleoma after cellulite treatment, which left scars even after treatment.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.